DermTech Alpha and Beta Analysis
| DMTKDelisted Stock | USD 0.04 0.02 71.36% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as DermTech. It also helps investors analyze the systematic and unsystematic risks associated with investing in DermTech over a specified time horizon. Remember, high DermTech's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to DermTech's market risk premium analysis include:
Beta 0.37 | Alpha 0.21 | Risk 0.0 | Sharpe Ratio 0.0 | Expected Return 0.0 |
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
DermTech |
DermTech Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. DermTech market risk premium is the additional return an investor will receive from holding DermTech long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in DermTech. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate DermTech's performance over market.| α | 0.21 | β | 0.37 |
DermTech Fundamentals Vs Peers
Comparing DermTech's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze DermTech's direct or indirect competition across all of the common fundamentals between DermTech and the related equities. This way, we can detect undervalued stocks with similar characteristics as DermTech or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of DermTech's fundamental indicators could also be used in its relative valuation, which is a method of valuing DermTech by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare DermTech to competition |
| Fundamentals | DermTech | Peer Average |
| Return On Equity | -1.22 | -0.31 |
| Return On Asset | -0.39 | -0.14 |
| Operating Margin | (5.33) % | (5.51) % |
| Current Valuation | 15.43 M | 16.62 B |
| Shares Outstanding | 34.96 M | 571.82 M |
| Shares Owned By Insiders | 2.62 % | 10.09 % |
| Shares Owned By Institutions | 18.09 % | 39.21 % |
DermTech Opportunities
DermTech Return and Market Media
The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Disposition of 2530 shares by Sun Kevin M of DermTech at 0.31 subject to Rule 16b-3 | 06/05/2024 |
2 | DermTech Files for Voluntary Chapter 11 Protection | 06/18/2024 |
3 | Why Is DermTech Stock Down 26 percent Today | 06/24/2024 |
About DermTech Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including DermTech or other delisted stocks. Alpha measures the amount that position in DermTech has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
DermTech Upcoming Company Events
As portrayed in its financial statements, the presentation of DermTech's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, DermTech's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of DermTech's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of DermTech. Please utilize our Beneish M Score to check the likelihood of DermTech's management manipulating its earnings.
| 7th of March 2024 Upcoming Quarterly Report | View | |
| 2nd of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 7th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with DermTech
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Consideration for investing in DermTech Stock
If you are still planning to invest in DermTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the DermTech's history and understand the potential risks before investing.
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |